Establishment Labs Holdings Inc. $ESTA Stock Holdings Lessened by Royce & Associates LP

Royce & Associates LP lessened its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 1.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 464,708 shares of the company’s stock after selling 7,608 shares during the quarter. Royce & Associates LP owned about 1.56% of Establishment Labs worth $29,820,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of ESTA. Arizona State Retirement System grew its stake in Establishment Labs by 5.6% in the 2nd quarter. Arizona State Retirement System now owns 5,057 shares of the company’s stock valued at $434,000 after buying an additional 268 shares during the last quarter. HighTower Advisors LLC lifted its position in Establishment Labs by 3.2% during the second quarter. HighTower Advisors LLC now owns 9,517 shares of the company’s stock worth $817,000 after acquiring an additional 293 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Establishment Labs during the second quarter worth approximately $32,000. KBC Group NV bought a new stake in shares of Establishment Labs during the first quarter worth approximately $28,000. Finally, Northwestern Mutual Wealth Management Co. acquired a new position in shares of Establishment Labs in the second quarter valued at approximately $43,000. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Price Performance

Establishment Labs stock traded up $2.13 during mid-day trading on Friday, reaching $70.75. The company had a trading volume of 367,353 shares, compared to its average volume of 513,910. The company has a market cap of $2.11 billion, a P/E ratio of -55.27 and a beta of 1.03. The company has a current ratio of 3.57, a quick ratio of 2.52 and a debt-to-equity ratio of 17.17. The business has a fifty day simple moving average of $66.04 and a 200 day simple moving average of $72.37. Establishment Labs Holdings Inc. has a fifty-two week low of $53.16 and a fifty-two week high of $97.59.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Friday, October 30th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.09). The firm had revenue of $71.99 million during the quarter, compared to analyst estimates of $66.81 million. Establishment Labs had a negative net margin of 14.56% and a negative return on equity of 196.38%. The business’s quarterly revenue was up 33.8% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.38) EPS. On average, equities research analysts predict that Establishment Labs Holdings Inc. will post -1.18 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ESTA. Needham & Company LLC increased their target price on Establishment Labs from $86.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. TD Cowen reduced their price target on Establishment Labs from $117.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, October 26th. JPMorgan Chase & Co. lifted their target price on Establishment Labs from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Monday, September 21st. Finally, Stifel Nicolaus initiated coverage on shares of Establishment Labs in a research report on Wednesday, October 14th. They issued a “buy” rating and a $85.00 target price for the company. Nine research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

Establishment Labs Company Profile

Establishment Labs Holdings Inc. is a medical technology company focused on breast health and aesthetics. Founded in 2004 by Juan José Chacón-Quirós, the Costa Rica-based company develops and manufactures products for breast augmentation and reconstruction. Its product portfolio includes Motiva breast implants, offered in different shapes and designs, as well as related technologies and products for plastic and reconstructive surgery. The company also develops solutions intended to support surgical procedures and patient care.